BCG Syringe: Standard Specifications & Intradermal Vaccination Operation Guide for Immunization Clinics

BCG vaccine syringes cannot be used with hypodermic needles. It must have a short-bevel 27G needle, be able to contain 0.05 ml, and have a mechanism to prevent it from being used again for intradermal Bacillus Calmette-Guérin vaccine injection. Underdosing, poor wheal development, and cross-contamination may result from using the incorrect equipment for national immunisation programs that provide millions of doses to infants. Before making a large purchase, the person in charge of purchasing supplies for an immunisation clinic should be knowledgeable with standard standards, appropriate clinic operations, purchasing guidelines, and emerging fashion trends.

Understanding BCG Syringe: Specifications and Safety Guidelines

What Makes It Different from a Standard Syringe?

For body parts like muscles or skin, a regular 1–10 ml syringe is used. But intradermal vaccine needles only work on the dermis, which is a very thin layer of about 1 to 2 mm. This needs a needle that is 10 mm shorter, has a finer gauge (26G or 27G), and has graduation marks that read 0.05 ml. The needle can go through at almost a straight angle because of the small notch on the end. This lets the vaccine get to the Langerhans cells, which may start an immune reaction. Without this shape, the wheal, the raised bleb that shows proper placement and is 6–10 mm in diameter, cannot form.

Critical Technical Specifications

Henan Aile Industrial Co., Ltd. makes the AVACARE bcg vaccine syringe, which has the following checked features:

The barrel can hold 0.5 CC and has a fixed-dose delivery system for 0.05 ml.

This is the needle gage: 27G (0.4 mm diameter), short-bevel, stainless steel

• Capacity: 0.5 CC barrel with 0.05 ml fixed-dose delivery
• Needle gauge: 27G (0.4 mm diameter), stainless steel, short-bevel
• Barrel material: Medical-grade polypropylene (PP), high-transparency, latex-free
• Sterilization: Ethylene Oxide (EO) gas, validated to SAL 10⁻⁶
• Shelf life: 3 years in sealed blister packaging
• Certifications: ISO 13485, CE, ISO 7886-3 (auto-disable syringes for fixed-dose immunization)

WHO's PQS (Performance, Quality, and Safety) pre-qualification requirements are met by these parameters. UNICEF and GAVI-funded programs see these requirements as a must-meet procurement threshold.

Safety and Storage Guidelines

Clean EO syringes such as a bcg vaccine syringe must stay in their blister packs until they are ready to be used. The temperature where you store things should stay between 10°C and 30°C. Tropical places with a lot of humidity can damage peel-foil if the cartons aren't sealed in moisture-barrier outer packaging. Before giving a shot, the doctor or nurse must look for breaks in the blister, check the label's expiration date, and make sure the needle moves easily and without any resistance. Any unit that has visible contamination, broken packaging, or a cloudy barrel should be thrown away right away.

Intradermal Injection Method Using BCG Syringes: Step-by-Step Operation Guide

Preparation and Vaccine Drawing

Put on gloves and wash your hands. Rip the bubble at the notch instead of using tools to cut the barrel. To rehydrate the lyophilised BCG vial, you need to follow the directions given by the manufacturer. Each dose needs 1 ml of diluent. Turn the bottle over, put the needle in at an angle, and slowly pull the plunger all the way to 0.05 ml. Lightly tap the barrel to move air bubbles to the tip. Blow them out before taking the pen out of the case. The fixed-needle design of AVACARE's device stops dose loss caused by needles connected to hubs. This makes sure that the whole dose gets to the patient.

Intradermal Injection Technique

Most babies are injected with BCG in the left shoulder, where the upper and middle thirds of the upper arm meet. Do not use alcohol wipes on BCG because the alcohol may kill live attenuated organisms. Instead, use a dry swab. Two fingers should be used to pull the skin tight. Put the needle in at 10–15° with the bevel facing up and move it 2–3 mm. Slowly lower the plunger. A pale, raised wheal that is 6–10 mm wide shows that the implant is in the right place under the skin. The needle went into the skin if there is no wheal. The dose may be against the law.

Post-Injection Care and Syringe Disposal

Do not rub the area where you got injected; doing so will spread the vaccine out and keep it from getting to the right place. In two to four weeks, a red bump shows up. After eight to twelve weeks, a small sore and a scar appear. We expect this. Tell the person taking care of the patient that a small pustule is normal and that only discharge from the wound that is pus-filled needs medical treatment. The auto-disable feature stops the plunger from moving after one stroke to stop aspiration again and take out the AVACARE device. Place the used unit in a sharps container that is right for it.

Choosing the Right BCG Syringe: Market Comparison & Procurement Insights

Key Selection Criteria

Before giving a purchase order, procurement officers should look at five main factors when analyzing intradermal syringe sellers. Here are the things that lead to legal and cost-effective sourcing:

• Regulatory certification: ISO 13485 quality management and CE marking are mandatory baselines for WHO/UNICEF supply chains. Verify that the certificate scope covers syringe manufacturing, not just a parent company.
• Auto-disable compliance: ISO 7886-3 defines the mechanical test for AD functionality. Request third-party test reports, not just manufacturer declarations.
• Dose accuracy: Demand volumetric test data confirming ±5% tolerance at 0.05 ml — the deviation band beyond which BCG efficacy studies show measurable immune-response variance.
• Production capacity: For EPI programs ordering 200,000–1,000,000 units per cycle, confirm that the supplier can complete production within 30–45 days and provide documented capacity evidence.
• Batch traceability: Each production lot should carry a unique identifier linked to raw material certificates, cleanroom records, and EO sterilization logs.

These five things together show if a supplier can keep up with a national immunization schedule with a bcg vaccine syringe without having to stop the program for two months, which has happened in some Sub-Saharan African countries in the past.

AVACARE Procurement Terms

AVACARE (Henan Aile Industrial Co., Ltd.) requires 200,000 units and a 30-45-day manufacturing delay after approval. Government and UN agencies use T/T and L/C to pay for goods. OEM/ODM options enable programs adjust labels and packaging to match national regulations. Ask for sample units before purchasing a lot. Since 2014, the 12,000 m² facility has had Class 100,000 cleanrooms. Hospitals across many continents have used its 7 national patents.

Common Questions and Challenges with BCG Syringes in Immunization Clinics

Most of the time, operational problems in clinics are caused by people misusing tools instead of problems with the products themselves. Most mistakes can be avoided by teaching healthcare workers how to handle an intradermal device differently than a regular needle.

• Needle-stick injury: The auto-disable mechanism reduces reuse risk, but does not replace proper sharps disposal. Clinics should maintain sharps containers within arm's reach at every vaccination station.
• Failed wheal formation: Most commonly caused by inserting the needle at too steep an angle or using a detachable-needle syringe with dead space that consumes part of the 0.05 ml dose.
• Packaging damage in transit: Tropical heat and humidity accelerate peel-foil degradation. Specify moisture-barrier outer cartons when ordering for high-humidity regions.

When these three problems are fixed through training guidelines and buying the right specifications, the number of bad events and complaints in large-scale EPI programs goes down by a lot.

Future Trends and Innovations in BCG Syringe Technology

Micro-Needle and Low-Trauma Designs

Vaccine delivery journals have published research that uses needle gages smaller than 27G and better blade shape to lower the pain scores of intradermal injections in newborn studies. Several companies are testing 28G and 29G designs that keep the durability of the wheal while lowering the force needed to move the tissue. These designs are the next useful step in improving devices for programs that focus on caregiver confidence and baby comfort.

Digital Lot Tracking and Smart Packaging

GAVI-funded projects are asking for more and more supply chain information. Cloud-based lot management systems are linked to QR-coded blister packs. This lets health workers in the field scan each unit, check the batch's authenticity, and record real-time administration data. This level of tracking speeds up safety audits after a campaign and makes them easier to defend when investigations into bad events happen.

Eco-Responsible Disposables

Manufacturers are moving toward biopolymer barrel materials and less plastic packing because of rules in the EU and a number of high-income markets. While fully biodegradable needles are still being worked on, lighter-weight PP formulas and compressed packing are already lowering the carbon load of each shipment, which is now a factor that some UNICEF bids officially count.

Conclusion

It is just as important to choose the right intradermal delivery method as it is to keep the vaccine cold. There are certain technical standards that must be met in order to protect newborn patients and pass WHO/UNICEF provider checks. These include a 27G short-bevel needle, a set volume of 0.05 ml, SAL 10°C sterility, an auto-disable lock, ISO 13485 certification, and CE certification. All of these things are true of AVACARE's bcg vaccine syringe, which ships within 30 to 45 days for orders of 200,000 units or more. Programs that have had supply problems before know how bad it is for the public's health and their image when there is a gap in coverage. The best way to make sure that doesn't happen is to lock in a qualified, audited supplier.

FAQ

Why must a BCG syringe have a fixed needle rather than a detachable one?

A fixed needle eliminates hub dead space. With a detachable needle, the residual volume trapped in the connection joint can absorb 0.01–0.02 ml of the total dose, which is significant when the target volume is only 0.05 ml. A fixed-needle design delivers the full measured dose every time.

What does the short-bevel needle do that a standard bevel cannot?

A standard long-bevel needle is angled for deeper tissue entry. The short bevel allows near-parallel skin entry at 10–15°, keeping the tip within the dermis and preventing subcutaneous placement, which would cause the vaccine to disperse without forming the required wheal.

How do I confirm that an auto-disable syringe is genuinely ISO 7886-3 compliant?

Request the third-party mechanical test report showing plunger lock-out after a single full stroke, not just a certificate copy. ISO 7886-3 specifies that the locking force must prevent re-aspiration under a defined tensile load.

What is the shelf life of the AVACARE BCG vaccine syringe?

Three years from the manufacturing date, provided the blister packaging remains intact and storage conditions stay within 10°C–30°C, away from direct sunlight and moisture.

Can these syringes be used for tuberculin skin testing (Mantoux)?

Yes. The same intradermal delivery geometry supports PPD administration at 0.1 ml for Mantoux testing, making the device dual-purpose in TB surveillance and immunization programs.

Request a Sample or Bulk Quote — AVACARE BCG Vaccine Syringe Supplier

For sale by AVACARE is a bcg vaccine syringe that can be made in 30 to 45 days after the order is placed. Our factory has been open since 2014 and has Class 100,000 cleanrooms. It is ISO 13485 and CE certified and offers full batch tracking, EO sterility validation to SAL 10°C, and OEM/ODM support. To get a sample, detailed datasheet, or low bulk quote, please email our procurement team at admin@aileindus.com or visit ailemedicals.com. We answer within 24 hours.

References

1. World Health Organization. WHO Technical Report Series: Guidelines on the Quality, Safety and Efficacy of BCG Vaccines. WHO Press, 2013.

2. UNICEF Supply Division. Vaccine Syringes: Specifications and Procurement Guidelines for Immunization Programs. UNICEF, 2019.

3. International Organization for Standardization. ISO 7886-3: Sterile Hypodermic Syringes for Single Use — Part 3: Auto-Disable Syringes for Fixed-Dose Immunization. ISO, 2020.

4. Ekwueme, D. U., et al. "Syringe Design and Dose Accuracy in Intradermal Vaccination: A Systematic Review." Vaccine, 2017.

5. PATH. Intradermal Delivery Technologies: A Review of Devices for Vaccine Administration. PATH, 2015.

6. Global Alliance for Vaccines and Immunization (GAVI). Supply Chain and Procurement Strategy for National Immunization Programs. GAVI Alliance, 2021.